Browse drugs

…cagrelor, P=1) and postoperative sICH (0.6% clopidogrel vs 0.6% ticagrelor, P=1). Functional outcomes, aneurysm occlusion at discharge, an…

….This case highlights a rare but important dual complication of infliximab therapy in a paediatric patient—pneumonitis and hepatotoxicity—…

…performance in gp120tgm (IDDF2026-ABS-0071 Figure 3. Effects of A.muciniphila gavage on learning and spatial memory abilities and neuronal da…

… window (>300x based on 14-day non-GLP tox studies).Conclusions LUS012, a highly selective Kv1.3 inhibitor with gut-restricted exposur…

… amplification to achieve synergistic antitumor effects between BBR and GO X, offering a novel paradigm for CRC treatment.Abstract …

…e from LTE wk 0 through wk 96 for inflammatory markers, hs-CRP (UPA15: -12.4, -12.0; UPA30: -12.7, -10.1) and FCP (UPA15: -2752, -326…

…9%/3.0% and 2.0%/3.9%/0% of patients receiving fipaxalparant QD/fipaxalparant BID/placebo, respectively. No patients met Hy’s law.Conclusions…

…gents were (dabigatran and warfarin) and were not (apixaban and rivaroxaban) available.Methods We included patients with anticoagulation-re…

…mazolam (~25–67×), flualprazolam (>20×), etizolam (~5–10×), and diazepam (1×). Quantitative data from 416 WEDINOS benzodiazepine samples…

…ITP) who are refractory to conventional treatments. Among them, eltrombopag and avatrombopag have demonstrated significant efficacy in incr…

…ents received upadacitinib(47.7%), 15 tofacitinib(34.1%), and 8 filgotinib(18.2%). Thirteen patients (29,5%) received concomitant treatmen…

…d (VA) binds strongly to albumin. In hypoalbuminaemia, the free valproic acid fraction (FVPA) – the pharmacologically active form – increases…